CVA Family Office LLC Acquires New Stake in Colgate-Palmolive (NYSE:CL)

CVA Family Office LLC bought a new position in shares of Colgate-Palmolive (NYSE:CLFree Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 2,869 shares of the company’s stock, valued at approximately $229,000.

A number of other large investors have also recently made changes to their positions in CL. Moneta Group Investment Advisors LLC boosted its position in Colgate-Palmolive by 90,253.2% in the 4th quarter. Moneta Group Investment Advisors LLC now owns 15,974,451 shares of the company’s stock valued at $1,258,627,000 after buying an additional 15,956,771 shares during the period. Norges Bank purchased a new stake in shares of Colgate-Palmolive in the fourth quarter valued at approximately $644,715,000. Renaissance Technologies LLC grew its stake in Colgate-Palmolive by 151.6% in the first quarter. Renaissance Technologies LLC now owns 5,688,786 shares of the company’s stock worth $431,381,000 after purchasing an additional 3,427,400 shares in the last quarter. Morgan Stanley increased its holdings in Colgate-Palmolive by 41.7% during the 4th quarter. Morgan Stanley now owns 11,370,549 shares of the company’s stock worth $895,886,000 after purchasing an additional 3,345,297 shares during the period. Finally, Caisse DE Depot ET Placement DU Quebec lifted its holdings in shares of Colgate-Palmolive by 1,915.2% in the 1st quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,793,287 shares of the company’s stock worth $135,985,000 after buying an additional 1,704,300 shares during the period. 80.41% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on CL shares. Bank of America raised shares of Colgate-Palmolive from a “neutral” rating to a “buy” rating and set a $90.00 price objective for the company in a research note on Friday, December 15th. Morgan Stanley increased their target price on Colgate-Palmolive from $85.00 to $93.00 and gave the company an “overweight” rating in a research report on Monday, January 29th. TheStreet raised Colgate-Palmolive from a “c+” rating to a “b+” rating in a research report on Friday, January 26th. Wells Fargo & Company boosted their target price on shares of Colgate-Palmolive from $80.00 to $88.00 and gave the stock an “equal weight” rating in a report on Monday, January 29th. Finally, Raymond James upgraded shares of Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 price target on the stock in a report on Monday, January 29th. Three analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $87.31.

View Our Latest Report on CL

Insider Activity at Colgate-Palmolive

In related news, Director C Martin Harris sold 2,760 shares of the stock in a transaction on Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total transaction of $233,220.00. Following the sale, the director now directly owns 19,272 shares of the company’s stock, valued at $1,628,484. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In related news, Director C Martin Harris sold 2,760 shares of the company’s stock in a transaction dated Wednesday, January 31st. The stock was sold at an average price of $84.50, for a total value of $233,220.00. Following the completion of the transaction, the director now owns 19,272 shares of the company’s stock, valued at approximately $1,628,484. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Noel R. Wallace sold 50,000 shares of the business’s stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $83.15, for a total value of $4,157,500.00. Following the completion of the sale, the chief executive officer now owns 274,179 shares of the company’s stock, valued at $22,797,983.85. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 232,371 shares of company stock worth $19,505,099. 0.34% of the stock is owned by corporate insiders.

Colgate-Palmolive Trading Up 0.5 %

Colgate-Palmolive stock opened at $89.20 on Monday. Colgate-Palmolive has a 52 week low of $67.62 and a 52 week high of $89.36. The stock has a 50-day moving average price of $85.02 and a 200 day moving average price of $78.76. The company has a quick ratio of 0.71, a current ratio of 1.11 and a debt-to-equity ratio of 8.59. The company has a market capitalization of $73.42 billion, a price-to-earnings ratio of 32.09, a price-to-earnings-growth ratio of 3.39 and a beta of 0.42.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its earnings results on Friday, January 26th. The company reported $0.87 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.85 by $0.02. The company had revenue of $4.95 billion during the quarter, compared to the consensus estimate of $4.89 billion. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The firm’s quarterly revenue was up 6.9% on a year-over-year basis. During the same period in the previous year, the firm posted $0.77 earnings per share. Sell-side analysts anticipate that Colgate-Palmolive will post 3.49 EPS for the current year.

Colgate-Palmolive Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.24%. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date is Friday, April 19th. Colgate-Palmolive’s dividend payout ratio (DPR) is 69.06%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.